PharmaCyte Biotech (PMCBD) News Today → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free PMCBD Stock Alerts $2.11 -0.01 (-0.47%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartStock AnalysisChart All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePMCB Stock Earnings: PharmaCyte Biotech Reported Results for Q3 2024investorplace.com - March 19 at 7:06 AMPharmaCyte Biotech Inc (PMCB)investing.com - February 22 at 8:52 PMExploring beauty’s biotech frontierft.com - October 27 at 1:21 AMPMCB PharmaCyte Biotech, Inc.seekingalpha.com - May 26 at 12:32 AMPharmaCyte Biotech Shares Up 13% to 52-Week High After Cash Tender Offermarketwatch.com - May 11 at 12:59 PMBaltimore Biotech Newsbizjournals.com - April 28 at 8:26 PMBiotech & Healthtechcrunch.com - March 30 at 3:47 AMPharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Valuefinance.yahoo.com - October 7 at 9:28 AMBLACK BIRD BIOTECH INCfinanznachrichten.de - September 28 at 11:55 PMPharmaCyte Biotech Rebukes Iroquois’ Commencement of Consent Solicitationfinance.yahoo.com - July 28 at 2:44 PMPharmaCyte Biotech Reports Positive Interim Results in Malignant Ascites Mouse Model Studyapnews.com - July 19 at 9:09 AMIROQUOIS CAPITAL ISSUES STATEMENT IN RESPONSE TO RECENT ACTIONS BY THE PHARMACYTE BIOTECH BOARD OF DIRECTORSfinance.yahoo.com - July 5 at 3:56 PMPharmaCyte Biotech announces $10M share buyback programseekingalpha.com - June 2 at 5:25 PMPharmaCyte Biotech stock rises on $10M stock buyback planseekingalpha.com - June 2 at 12:25 PMPharmaCyte Biotech to Implement $10-Million Share Repurchase Programapnews.com - June 2 at 12:25 PMPharmaCyte Biotech Initiates Studies to Confirm Its Pancreatic Cancer Therapy Can Treat Malignant Ascitesstockhouse.com - May 23 at 10:26 AMPharmaCyte Biotech, Inc. (PMCB)finance.yahoo.com - February 10 at 11:13 PMPharmaCyte Biotech to Present at H.C. Wainwright BioConnect Conferencefinance.yahoo.com - January 6 at 12:39 PMPharmaCyte Biotech Successfully Completes 36 Month Master Cell Bank Stability Studybusinesswire.com - December 28 at 11:37 AMPharmaCyte Biotech Successfully Completes Cytochrome P450 Site of Integration DNA Sequencing Assaystockhouse.com - December 8 at 1:16 PMPharmaCyte Biotech Launches Malignant Ascites Program with Commencement of Pivotal Preclinical Studybusinesswire.com - November 30 at 9:34 AMPharmaCyte Biotech Announces Cell Encapsulation Technology Material Does Not Cause Skin Irritationfinance.yahoo.com - November 12 at 9:53 AMWhy Are PharmaCyte Shares Moving Higher On Thursday?feeds.benzinga.com - September 16 at 2:23 PMPharmaCyte Biotech Announces Closing of $15-Million Public Offeringfinance.yahoo.com - August 12 at 4:04 PM Get PharmaCyte Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PMCBD and its competitors with MarketBeat's FREE daily newsletter. Email Address These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy PMCBD Media Mentions By Week PMCBD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PMCBD News Sentiment▼0.000.34▲Average Medical News Sentiment PMCBD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PMCBD Articles This Week▼00▲PMCBD Articles Average Week Get PharmaCyte Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PMCBD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ALBT News FNCH News ELOX News KRBP News GMDA News WINT News PALI News TCON News FRTX News SQZ News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PMCBD) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsAI finds its first serious applicationWall Street StarForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHe Is Giving Away BitcoinCrypto Swap ProfitsTrump is sounding the alarmPreserve GoldRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PharmaCyte Biotech Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
